Detalhe da pesquisa
1.
Diagnostic Utility of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive Dementia.
Ann Neurol
; 95(2): 299-313, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897306
2.
Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset.
Ann Neurol
; 95(5): 951-965, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400792
3.
Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals.
Ann Neurol
; 95(3): 495-506, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38038976
4.
Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression.
Brain
; 146(7): 2944-2956, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542469
5.
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease.
Alzheimers Dement
; 15(5): 655-665, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846386
6.
Correlational analyses of biomarkers that are harmonized through a bridging study due to measurement errors.
Stat Methods Med Res
; 33(2): 185-202, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994004
7.
CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly.
Sci Adv
; 10(14): eadk3674, 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569027
8.
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease.
Brain Commun
; 6(2): fcae081, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38505230
9.
Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests.
Nat Med
; 30(4): 1085-1095, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38382645
10.
Predicting continuous amyloid PET values with CSF and plasma Aß42/Aß40.
Alzheimers Dement (Amst)
; 15(1): e12405, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36874595
11.
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease.
Nat Aging
; 3(4): 391-401, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37117788
12.
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.
Lancet Neurol
; 22(1): 55-65, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517172
13.
A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer's disease.
Brain Commun
; 4(2): fcac045, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35415607
14.
Comparison of plasma and CSF biomarkers in predicting cognitive decline.
Ann Clin Transl Neurol
; 9(11): 1739-1751, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36183195
15.
Effect of Race on Prediction of Brain Amyloidosis by Plasma Aß42/Aß40, Phosphorylated Tau, and Neurofilament Light.
Neurology
; 99(3): e245-e257, 2022 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35450967
16.
Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach.
J Alzheimers Dis
; 89(1): 193-207, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35871346
17.
Clinical and Paraclinical Measures Associated with Outcome in Cerebral Amyloid Angiopathy with Related Inflammation.
J Alzheimers Dis
; 80(1): 133-142, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33492294
18.
Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25.
Neurobiol Aging
; 102: 64-72, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33765432
19.
African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants.
Neurol Genet
; 7(2): e571, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33884297
20.
Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
Neurology
; 96(20): e2546-e2557, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33795390